(1999) 13, Suppl. 1, 87–89  1999 Stockton Press All rights reserved 0887-6924/99 $12.00 http://www.stockton-press.co.uk/leu Immunophenotypic and functional characterization of human mononuclear cells K Paloczi

National Institute of Haematology and Immunology, Budapest, Hungary

Human umbilical cord blood (CB) represents a unique source GM).7,8 Besides the different culture systems immunofluo- of transplantable hematopoietic progenitor cells. Potential rescence and flow cytometry can be regarded as a reliable advantages of using CB relate to the high number and quality of hematopoietic stem and progenitor cells present in the circu- and rapid method for detection of early stem/progenitor cells. lation at birth and to the relative immune immaturity of the new- The CD34 is of particular interest because it represents born immune cells. Discussed in this review are: (a) Quantity the only cell-surface antigen identified by monoclonal anti- and quality of immature hematopoietic stem and progenitor bodies (MoAb), whose expression within the hematopoietic cells from cord blood; (b) Immune cells in cord blood including system is restricted to primitive progenitor cells of all the number of B- and T-lymphocytes, as well as natural killer 9 cells and characterization of their functional capacities; (c) The lineages. 1,2 need of an international CB transplantation registry and the According to the previous reports, cord blood represents availability of cord blood banks. Although still in its infancy, a rich source of hematopoietic stem/progenitor cells, but human CB progenitor cells hold considerable potential for in CD34+ cell enumeration was not reported for these studies. vitro expansion and to transplant the adult recipients. In However, Broxmeyer and co-workers10 have confirmed that addition, the CB repopulating progenitor cells can serve as tar- gets for gene transfer and long-term treatment of genetic the single primitive CD34-positive human umbilical cord inherited diseases, and some immunodeficiencies. blood hematopoietic progenitors have a very high proliferative and replating potential and may at least in part be associated with the successful hematopoietic repopulating capacity of umbilical cord blood cells. + Introduction Several groups have recently analyzed the CD34 cells present in the different cell sources used for transplantation 10–19 Human placental/umbilical cord blood (CB), as a source of including human CB. These data indicate that using only hematopoietic progenitor cells for (BM) recon- one-color CD34 analysis may not provide sufficient infor- + stitution, has been shown to yield successful transplants from mation,12,15 but sensitive detection and enumeration of CD34 siblings1–3 and more recently from unrelated donors.4,5 In cells is required.12,13,15 The widespread use of CD34 comparison with BM, the collection of CB is easier and the expression as a measure of the transplant potential of hemato- transmission of certain infectious agents, particularly cytome- poietic tissue also means that it is important to establish any galovirus, to recipients, is much less common.5 Most antibody- or tissue-related differences in levels of importantly, CB graft may result in decreased incidence of expression.14 As a result of the different levels of detection by acut graft-versus-host disease (GVHD) even in partially mis- different MoAbs, the apparent number of CD34+ cells vary matched cases.3,4 The most important potential disadvantage by approximately six-fold.14 Furthermore, the kinetics of the of CB is the limited nucleated cell content of donation (a mean engraftment seems to be depending on the composition of of 117 mls ± 17 s.d. and a mean of 15.6 × 109/l ± 10.3 CD34 subpopulations, eg the distribution of the early and late nucleated cells).5,6 myeloid and B-lymphoid progenitor cells.15,17 Since the first CB transplantation in 19882 the number of A novel developed in vivo functional assay for primitive transplantations with CB hematopoietic cells is increasing and human hematopoietic cells is based on their ability to repopu- nowadays more than 200 have performed worldwide. There late the BM of severe combined immunodeficient (SCID) and is wide international agreement that a pilot clinical CB trans- non-obese diabetic/SCID (NOD/SCID) mice.18 These results plant study is required to evaluate results in comparison with also confirm that CB is enriched for the primitive hematopo- related and unrelated marrow donor transplants. Within the ietic cells compared with BM or mobilized PB, an observation framework of this program the Eurocord Transplant Group that has important implications for clinical transplantation and was established with the purpose of studying the properties of expansion strategies. hematopoietic stem cells present in placental blood at birth Engraftment will depend not only on the number of progeni- for clinical use in patients affected predominantly by hematol- tors, but also on the quality of these cells for proliferation and ogical diseases.6 self-renewal. These qualities of stem and progenitor cells appear to be high. It has been demonstrated that committed hematopoietic progenitor cells are at least as numerous in Quantity and quality of immature hematopoietic stem cells cord blood as in normal BM.13,15,16 Cord blood cells can be from cord blood extensively expanded in suspension culture with different combinations of cytokines,20 as well as in NOD/SCID mice17 The use of human cord blood as source of transplantable hem- and other murine model in vivo.21 Thus, immature hematopo- atopoietic stem and progenitor cells began with a multi-insti- ietic stem cells and progenitor cells appear to be of good qual- tutional laboratory study.1,7 A common approach to assess the ity in cord blood.16 quality of stem cell grafts relies on methylcellulose-based col- ony assays for lineage-committed hematopoietic progenitor cells as colony-forming units granulocyte/macrophage (CFU- Abstracts S88 Immune cells in cord blood est that little cytotoxic activity is generated by cord blood cells even after primary, secondary and tertiary stimu- There has been little or no GVHD detected in children receiv- lation by allogeneic cells.10,13,16,31,34 The maximal responses ing HLA-matched or one antigen mismatched sibling cord observed in CB T cells were much less than those of adult T blood,2,3,7,16,22 and results using unrelated CB have been simi- cells, whereas the Con-A-induced proliferative responses of lar.4,5,16 There is evidence that immune cells from CB react these cells showed no significant differences. The decreased differently to those in adults. Monocyte/macrophage and T- responses of CB T cells were due to their lower efficiency in and B-lymphocytes are the major immune response cells. It activating the cellular events in T cell activation and prolifer- has been reported that a low antigen presenting ability found ation phase. Cord blood T cells have significantly less ability in CB monocyte/macrophage is due to their immaturity.16,23 than adult T cells to produce IL-2 and express functional IL- 2R complexes, especially high-affinity IL-2R complexes, and HLA-DR. These functional characteristics may be related to Immunologic characterization of cord blood the immaturity of cord blood T cells. B-lymphocytes Results obtained from our own experiments also indicate a distinct cytokine production profile in CB cells as compared It is known that newborn B cells are capable of producing with PB.13,30 A reduction was observed in the potential of CB amounts of IgM antibody comparable with those of adult B cells to produce the Th-1 cell-derived cytokines, IFN␥ and IL- cells, but their capacity to produce IgG or IgA is remarkably 24 2 upon stimulation with PHA or allogeneic cells. On the con- reduced. In humans, during fetal development the trary, a slight increase was found in the production of IL-6 by populations show distinct phenotypes at different tissue sites. ␥ + + − alloactivated CB cells. The reduction of IFN and IL-2 could Besides conventional B cells (CD20 , CD24 , CD5 ) in fetal be associated with the presence of immature, naive T cells liver and bone marrow a significant fraction of fetal spleno- in CB. cytes are CD5+ B-lymphocytes.25 At birth, most IgM+ human umbilical cord blood B-lymphocytes co-express the CD5 anti- gen, too.26 Gluckman et al published that 68% of the CD19+ Cord blood natural killer (NK) cells: Cord blood NK cells cord blood B-lymphocytes proved to be CD5 antigen posi- − + tive.27 CD5+ B-lymphocytes share many properties of Ly-1 are CD3 CD56 cells expressing CD2, CD7, C11a-c, CD18, CD38, CD45RA and p75 IL-2 .13,26,35 Only small murine B cells including self-replenishment and feedback + + 13,26,35 regulation of development. This unique population of B cells amounts of CD3 CD16 cells exist in CB. Cord blood (CD5+ B cells) is known as B1a lymphocytes preferentially NK cell activity is low or similar to that in adult blood but lymphokine activated killer cell activity is readily induced in generated from fetal/neonatal sources of progenitors. Func- 35,36 tionally, the antibodies produced by B1a cells are charac- CB by cytokines such as IL-2 or IL-12. terized by the predominance of IgM, minimal hypermutation and high frequency of low affinity, polyreactive, self-reactive In summary, umbilical cord blood stem cells are an alternative specificities.28 source of transplantable cells that can be used to reconstitute Our special interest was characterizing the CB B-lympho- hematopoiesis in children with malignant and non-malignant cytes studying differential expression of B cell-associated anti- diseases after treatment with myeloablative doses of chemo- gens on CD5+ B cells (B1a) and CD5− B cells (B1b) using therapy. The higher frequency of repopulating cells in CB MoAb panel from the 6th International Workshop on Human compared with adult tissues suggests that CB may be better Differentiation (Kobe, 1996).29,30 Based on our source of stem cells both for transplantation and ex vivo recent results, cord blood CD5+ B cells are expressing CD19, manipulations, such as retroviral infection and gene therapy CD20, CD22, CD24, HLA-DR pan-B and CD32, CD39, or stem cell expansion. To establish a cryopreserved human CD76, CD79, CD137, sIgM and CD9 B-subpopulation anti- CB bank of unrelated donors for clinical transplantation is gens.29,30 According to their immunophenotype the cord important. blood B1a cells can be regarded as CD5+, CD9+, sIgM+ and pan-B antigen positive immature naive B cells not yet expos- ing to environmental antigens. However, the lack of memory Acknowledgements cells in CB involves some functional deficiencies in the recovering B-lymphocytes post-transplant. Our studies reported in this review were supported by grant from the National Scientific Research Foundation (OTKA Grant No. T 017638). Immunologic characterization of cord blood T-lymphocytes and NK cells References Number and phenotype of cord blood T-lymphocytes: In cord blood, about 50% of low density mononuclear cells 1 Broxmeyer HE, Douglas GW, Hangoc C, Cooper S, Bard J, English 13,16,22,26,31–33 express CD3, compared to 70% in adult blood. D, Arny M, Thomas L, Boyse EA. Human umbilical cord blood as However, phenotypic analysis of T cell subsets (CD4, CD8) a potential source of transplantable hematopoietic stem/progenitor revealed no significant difference between adult and cord cells. Proc Natl Acad Sci USA 1989; 86: 3828–3832. blood. Newborn T cells have lower level of both IL-2 recep- 2 Gluckman E, Broxmeyer HE, Auerbach AD, Friedman H, Douglas tors and HLA-DR than do adult T cells. The CD4+ T cells rep- GW, Devergie A, Esperou H, Thierry D, Socie G, Lehn P, Cooper S, English D, Kurzberg J, Bard J, Boyse EA. Hematopoietic reconsti- resents 31% of lymphocytes with a great prevalence of the tution in a patient with Fanconi’s by means of umbilical + + 16 CD4 /CD45RA populations. cord blood from HLA-identical sibling. New Engl J Med 1989; 321: 1174–1178. 3 Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E. Function of the T-lymphocytes in cord blood: It is of inter- Allogeneic sibling umbilical cord blood transplantation in children Abstracts S89 with malignant and non-malignant disease. Lancet 1995; 346: 20 Ruggieri L, Heimfeld S, Broxmeyer HE. Cytokine-dependent ex 214–219. vivo expansion of early subsets of CD34+ cord blood myeloid pro- 4 Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin genitors is greatly enhanced by cord , but expansion EC, Ciocci G, Carrier C, Stevens CE, Rubinstein P. Placental blood of the more mature subsets of progenitors is favored. Blood Cells as a source of hematopoietic stem cells for transplantation into 1994; 20: 436–454. unrelated recipients. N Engl J Med 1996; 335: 157–166. 21 Scaradavou A, Isola L, Rubinstein P, Galperin Y, Najfeld V, Berlin 5 Rubinstein P, Rosenfield RE, Adamson JW, Stevens CE. Stored pla- D, Gordon J, Weinberg RS. A murine model for human cord blood cental blood for unrelated bone marrow reconstitution. Blood transplantation: near-term fetal and neonatal peripheral blood 1993; 81: 1679–1690. cells can achieve long-term bone marrow engraftment in sub- 6 Gluckman E. Cord blood transplantation in Europe. Trends Onco- lethally irradiated adult recipients. Blood 1997; 89: 1089–1099. Hematol 1996; 4: 10–11. 22 Varadi G, El-Chalal U, Brautbar C, Nagler A. Human umbilical 7 Broxmeyer HE, Cooper S, Yoder M, Hangoc G. Human umbilical cord blood for hematopoietic progenitor cells transplantation. cord blood as a source of transplantable hematopoietic stem and Leuk 1995; 20: 51–58. progenitor cells. In: Mu¨ller-Sieburg C, Torok-Storb B, Visser J, 23 Taylor S, Bryson YJ. Impaired production of ␥-interferon by new- Storb R (eds). Hematopoietic Stem Cells. Springer Verlag: Berlin, born cells in vitro is due to a functionally immature macrophage. 1992, pp 195–203. J Immunol 1985; 134: 1493–1497. 8 Sprangrude GL, Heimfeld S, Weissman IL. Purification and charac- 24 Anderson U, Bird AG, Britton S, Palacios R. Humoral and cellular terization of mouse hematopoietic stem cells. Science 1988; 241: 58–65. immunity in human studied at the cell level from birth to 2 years 9 Reisbach G, Bartke I, Kempkes B, Kostka G, Ellwart J, Birner A, of age. Immunol Rev 1981; 57: 5–38. Thalmeier K, Mailhammer R, Bornkamm GW, Ullrich A, Do¨rmer 25 Bofill M, Janossy G, Janossa M, Burford GD, Seymour GJ, Wernet P. Characterization of hemopoietic cell population from human P, Kelemen E. Human B cell development. II. Subpopulations in cord blood expressing c-. Exp Hematol 1993; 21: 74–79. the human fetus. J Immunol 1985; 134: 1531–1538. 10 Lu L, Xiao M, Shen R-N, Grigsby S, Broxmeyer HE. Enrichment, 26 Rabian-Herzog C, Lesage S, Gluckman E. Characterization of lym- characterization, and responsiveness of single primitive CD34+++ phocyte subpopulation in cord blood. Bone Marrow Transplant human umbilical cord blood hematopoietic progenitors with high 1992; 9 (S1): 64–67. proliferative and replating potential. Blood 1993; 81: 41–48. 27 Hardy RR, Li Y-S, Hayakawa K. Distinctive developmental origins + 11 Fritsch G, Buchinger P, Printz D. Use of flow cytometric CD34 and specificities of the CD5 B-cell subset. Sem Immunol 1996; analysis to quantify hematopoietic progenitor cells. Leuk Lym- 8: 7–44. phoma 1993; 10: 443–451. 28 Stall AM, Wells SM. Introduction: B-1 cells: origin and function. 12 Sutherland DR, Keating A, Nayar R, Anania S, Stewart AK. Sensi- In: Stall AM, Wells SM (eds). Seminars in Immunology. B-1 cells: tive detection and enumeration of CD34+ cells in peripheral and Origin and Functions. Academic Press: Cambridge, UK, 1996, cord blood by flow cytometry. Exp Hematol 1994; 22: 1003– pp 1–2. 1010. 29 Ezsi R, Demeter J, Valent S, Paulin F, Milosevits J, Farkas P, Sziget- 13 Milosevits J, Pocsik E, Schmidt B, Remenyi P, Intodi ZS, Reti M, vari CS, Varadi E, Batai A, Karadi A, Paloczi K. Reactivity of per- Batai A, Illes P, Mihalik R, Petranyi GG, Paloczi K. Immunopheno- ipheral blood, cord blood and B-CLL cells with the workshop typic and functional characteristics of haemopoietic cells from unclustered B cell panel antibodies. Tiss Antigen 1996; 48: 372 human cord blood. Scand J Immunol 1995; 42: 493–500. (Abstr.). 14 Titley I, Healy LE, Scott M, Amos TAS, Gordon MY. Extent of varia- 30 Ezsi R, Valent S, Paulin F, Kotlan B, Pocsik E, Petranyi G, Paloczi bility inherent in measurements of CD34-positive cells in different K. Immunophenotypes of cord blood B1a and B1b lymphocytes. human haemopoietic tissues. Bone Marrow Transplant 1995; 16: J Mol Med 1997; 75: B187 (Abstr.). 611–616. 31 Risdon G, Gaddy J, Broxmeyer HE. Allogeneic responses of 15 Fritsch G, Stimpfl M, Kurz M, Printz D, Buchinger P, Fischmeister human umbilical cord blood. Blood Cells 1994; 20: 566–572. G, Hoecker P, Gadner H. The composition of CD34 subpopula- 32 Hannet I, Erkeller-Yuksel F, Plydyard P, Deneys V, Debruyere M. tions differs between bone marrow, blood and cord blood. Bone Developmental and maturational changes in human blood lym- Marrow Transplant 1996; 17: 169–178. phocyte subpopulation. Immunol Today 1992; 13: 215–216. 16 Lu L, Shen R-N, Broxmeyer HE. Stem cells from bone marrow, 33 Keever CA. Characterization of cord blood lymphocyte subpopul- umbilical cord blood and peripheral blood for clinical application: ation. J Hematother 1993; 2: 203–206. current status and future application. Crit Rev Oncol/Hematol 1996; 22: 61–78. 34 Risdon G, Gaddy J, Broxmeyer HE. Proliferative and cytotoxic 17 Paloczi K, Ezsi R, Pocsik E, Milosevits J, Petranyi G. Immunophen- responses of human cord blood T lymphocytes following allo- otypic and functional characterization of cord blood lymphocytes. geneic stimulation. Cell Immunol 1994; 154: 14–24. J Mol Med 1997; 75: B187 (Abstr.). 35 Phillips JH, Hori T, Nagler A, Bhat N, Spits H, Lanier LL. Ontogeny 18 Wang CY, Doedens M, Dick JE. Primitive hematopoietic cells are of human natural killer (NK) cells: fetal NK cells mediate cytolytic enriched in cord blood compared with adult bone marrow or function and express cytoplasmic CD3 epsilon, delta . J mobilized peripheral blood as measured by the quantitative in Exp Med 1992; 175: 1055–1066. vivo SCID-repopulating cell assay. Blood 1997; 89: 3919–3924. 36 Gaddy J, Risdon G, Broxmeyer HE. Cord blood 19 Wagner JE. Regulation of placental and umbilical cord blood stem are functionally and phenotypically immature but readily respond cells. J Hematother 1997; 6: 1–3. to IL-2 and IL-12. J Interfer Cytok Res 1995; 15: 527–536.